|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4162 | (2006.01) |
| C07D 519/00 | (2013.01) | ||
| A61K 31/4375 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07D 498/04 | (2006.01) |
| (11) | Patento numeris | 3848027 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21158231.7 |
| Europos patento paraiškos padavimo data | 2014-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361908333 P | 2013-11-25 | US | |
| 201461985035 P | 2014-04-28 | US |
| (72) |
HUNT, Hazel , GB
WALTERS, Iain , GB
GOURDET, Benoit , GB
|
| (73) |
Corcept Therapeutics Incorporated ,
149 Commonwealth Drive, Menlo Park, CA 94025,
US
|
| (54) | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |